Jumlah Kasus
Sumber Mean Adenocarcinoma
Periode Data Ras Kulit Usia, Adenocarcinoma With Squamous Mixed Clear Jumlah
Penelitian Lokasi Rekrutmen Matching Factors Histologi† Putih, % Tahun‡ Endometrioid NOS Differentiation Serous Cell Cell Mucinous Kontrol
Estrogen, Diet, New Jersey 2001-2005 Usia (5-year group) Registry 90.1 62.8 292 96 9 26 6 4 3 464
Genetics, and
Endometrial
Cancer (EDGE)
Fred Hutchinson Washington 1994-2005 Usia (5-year group) Registry 95.5 59.7 463 260 35 35 20 3 6 847
Cancer Research
Center (FHCRC)
Hawaii Hawaii 1988-1993 Usia ( 2.5 years), Path/registry 29.1 62.5 93 192 19 4 3 2 3 335
Endometrial ethnicity
Cancer Study
(HAW)
Polish Endometrial Poland 2000-2003 Usia ( 5 years), site Path/slide 100.0 57.2 312 110 10 68 5 4 1,829
Cancer Study
(PECS)
Patient New York 1982-1998 Usia ( 5 years) Registry 97.4 62.9 72 327 33 19 5 8 2 504
Epidemiologic
Data System
(PEDS)
Shanghai China 1997-2004 Usia ( 5 years) Path/slide 0.0 54.6 997 60 7 15 3 8 2 1,205
Endometrial
Cancer Study
(SECS)
Turin Case Control Italy 1998-2008 — Path 100.0 60.9 180 12 4 9 3 10 2 266
Study (TURIN)
US Endometrial 5 US clinics 1987-1990 Usia ( 5 years), race, Path 93.1 58.8 18 224 47 11 1 7 10 303
Cancer Study telephone exchange
(US)
USC LA case- Los Angeles 1987-1993 Usia ( 5 years) Path 100.0 63.1 38 666 45 7 1 8 791
control (USC)
Women’s Insight Philadelphia 1999-2002 Usia ( 5 years), race Path 78.9 61.7 376 168 28 6 7 1,574
and Shared
Experience
(WISE)
Semua case-control 79.7 60.0 4,806 2,242 496 281 285 106 76 10,919
Pooled studies 85.4 63.9 7,246 4,830 777 508 346 196 166 35,312
Singkatan: AARP, American Association of Retired Persons; NIH, National Institutes of Health; NOS, not otherwise specified.
Berdasarkan wanita yang termasuk dalam analis gabungan (misalnya, setelah melakukan ekslusi pada wanita yang data faktor risikonya tidak ada).
†Path= tinjauan dari pathology report; slide = tinjauan dari pathology slides; registry= tipe histologi/kode yang dilaporkan oleh cancer registry.
‡Usia saat didiagnosis dan usia saat wawancara /tanggal kontrol.
§NHS mengkelompokkan endometrioid, adenocarcinoma NOS, dan mucinous tumors dalam satu kategori.
Tabel 2. Karakteristik Wanita dalam Analisis Gabungan Berdasarkan Case – Control Status dan histologi
Kasus
Adenocarcinoma
Adenocarcinoma With Squamous
Endometrioid NOS Differentiation Serous Mixed Cell Clear Cell Mucinous Kontrol
(n 7,246) (n 4,830) (n 777) (n 508) (n 346) (n 196) (n 166) (n 35,312)
Kasus
Adenocarcinoma With
Endometrioid Adenocarcinoma NOS Squamous Differentiation Serous Mixed Cell Clear Cell Mucinous
Kasus
Adenocarcinoma With
Endometrioid Adenocarcinoma NOS Squamous Differentiation Serous Mixed Cell Clear Cell Mucinous
Kohort Case-Control Path Review Registry Kohort Case-Control Path Review Registry
Faktor Risiko OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI OR 95% CI
Indeks massa tubuh, kg/m2
25 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
25 - 30 1.32 1.23 to 1.43 1.60 1.48 to 1.73 1.53 1.40 to 1.66 1.40 1.31 to 1.50 1.14 0.86 to 1.52 1.19 0.95 to 1.48 1.08 0.84 to 1.40 1.24 0.98 to 1.57
30 - 35 2.44 2.23 to 2.67 2.61 2.36 to 2.88 2.45 2.19 to 2.74 2.56 2.35 to 2.78 1.76 1.25 to 2.47 1.72 1.32 to 2.23 1.55 1.13 to 2.12 1.90 1.44 to 2.50
35 - 40 4.15 3.65 to 4.72 4.84 4.20 to 5.58 4.45 3.76 to 5.26 4.46 3.98 to 5.00 2.22 1.37 to 3.61 2.15 1.48 to 3.11 2.21 1.42 to 3.45 2.12 1.43 to 3.16
$ 40 6.66 5.66 to 7.83 7.86 6.54 to 9.44 8.45 6.69 to 10.67 6.73 5.83 to 7.75 3.08 1.69 to 5.61 3.29 2.11 to 5.12 4.20 2.44 to 7.23 2.64 1.63 to 4.30
P trend .0001 .0001 .0001 .0001 .0001 .0001 .0001 .0001
Indeks massa tubuh, per
2
2 kg/m 1.20 1.18 to 1.21 1.22 1.20 to 1.23 1.21 1.19 to 1.23 1.20 1.19 to 1.22 1.12 1.08 to 1.17 1.12 1.08 to 1.15 1.13 1.08 to 1.17 1.11 1.08 to 1.15
Usia Menarke, tahun
11 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
11-12 0.90 0.78 to 1.04 0.88 0.75 to 1.03 0.90 0.74 to 1.09 0.88 0.77 to 1.00 0.62 0.40 to 0.97 0.72 0.48 to 1.07 0.67 0.40 to 1.11 0.67 0.46 to 0.96
13-14 0.87 0.75 to 0.99 0.83 0.71 to 0.96 0.82 0.68 to 0.97 0.86 0.76 to 0.97 0.52 0.34 to 0.79 0.71 0.49 to 1.03 0.68 0.42 to 1.10 0.58 0.41 to 0.81
$ 15 0.72 0.61 to 0.86 0.69 0.59 to 0.82 0.68 0.56 to 0.83 0.73 0.63 to 0.84 0.52 0.31 to 0.90 0.52 0.33 to 0.81 0.45 0.26 to 0.78 0.58 0.37 to 0.90
P trend .0002 .0001 .0001 .0001 0.01 .008 .008 .009
Paritas
0 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
1 0.80 0.71 to 0.90 0.70 0.59 to 0.76 0.64 0.56 to 0.74 0.79 0.71 to 0.88 1.06 0.69 to 1.61 0.72 0.52 to 1.01 0.67 0.45 to 0.98 0.98 0.69 to 1.40
2 0.77 0.70 to 0.85 0.57 0.51 to 0.63 0.56 0.49 to 0.63 0.73 0.67 to 0.80 0.84 0.59 to 1.21 0.57 0.43 to 0.76 0.51 0.37 to 0.72 0.80 0.60 to 1.07
3 0.63 0.57 to 0.69 0.48 0.43 to 0.54 0.46 0.40 to 0.52 0.61 0.56 to 0.67 0.65 0.46 to 0.93 0.50 0.38 to 0.67 0.46 0.32 to 0.65 0.64 0.48 to 0.85
$4 0.47 0.41 to 0.53 0.32 0.28 to 0.38 0.33 0.28 to 0.39 0.44 0.39 to 0.49 0.58 0.36 to 0.92 0.51 0.36 to 0.74 0.54 0.35 to 0.82 0.51 0.34 to 0.75
P trend .0001 .0001 .0001 .0001 .001 .0001 .0002 .0001
Penggunaan kontrasepsi
oral
Tidak pernah 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Pernah 0.76 0.71 to 0.82 0.68 0.62 to 0.73 0.68 0.62 to 0.74 0.75 0.70 to 0.81 0.81 0.62 to 1.07 0.68 0.54 to 0.86 0.59 0.44 to 0.79 0.86 0.68 to 1.08
Riwayat merokok†
Tidak pernah 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Dahulu 0.88 0.83 to 0.95 0.84 0.78 to 0.91 0.84 0.77 to 0.92 0.88 0.82 to 0.94 0.87 0.67 to 1.12 0.62 0.49 to 0.77 0.60 0.47 to 0.79 0.79 0.63 to 0.98
Saat ini 0.68 0.61 to 0.76 0.61 0.54 to 0.68 0.60 0.52 to 0.68 0.68 0.61 to 0.75 0.73 0.49 to 1.11 0.52 0.38 to 0.72 0.52 0.36 to 0.75 0.66 0.46 to 0.93
Diabetes‡
Tidak 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00
Ya 1.21 1.06 to 1.38 1.31 1.18 to 1.47 1.34 1.18 to 1.52 1.24 1.10 to 1.39 1.15 0.73 to 1.82 1.76 1.31 to 2.37 1.53 1.05 to 2.24 1.55 1.13 to 2.14